share_log

康弘药业:北京市通商(深圳)律师事务所关于成都康弘药业集团股份有限公司2021年股票期权激励计划注销部分股票期权及首次授予部分股票期权第三个行权期、预留授予部分股票期权第二个行权期行权条件成就的法律意见书

Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Tongshang (Shenzhen) Law Firm on the Cancellation of Certain Stock Options and the Achievement of Exercise Conditions for the Third Exercise Period of Certain Stock Options and the Reservation of Granting Certain Stock Options for the Second Exercise Period of Chengdu Kanghong Pharmaceutical Group Co., Ltd.'s 2021 Stock Option Incentive Plan

SZSI ·  Aug 23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more